Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates

Cancer

Volumn 117, Issue 17, 2011, Pages 3943-3952

  Groome, Patti A ^a   Rohland, Susan L ^a   Siemens, D Robert ^b   Brundage, Michael D ^a   Heaton, Jeremy ^b   MacKillop, William J ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

cohort studies; comorbidity; health status indicators; prognosis; prostatic neoplasms; survival analysis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANADA; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; GLEASON SCORE; HEART DISEASE; HUMAN; KIDNEY DISEASE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COMORBIDITY; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSTATIC NEOPLASMS; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 80051926557     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25984     Document Type: Article

References (41)

1. Fouad MN, Mayo CP, Funkhouser EM, Hall HI, Urban DA, Kiefe CI,. Comorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease. J Clin Epidemiol. 2004; 57: 721-729. (Pubitemid 39195222)
2. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J,. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol. 1996; 156: 127-132. (Pubitemid 26185654)
3. Fowler JE Jr, Terrell FL, Renfroe DL,. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol. 1996; 156: 1714-1718; comment 1724. (Pubitemid 26344025)
4. Alibhai SMH, Leach M, Tomlinson G, et al. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst. 2005; 97: 1525-1532. (Pubitemid 41631952)
5. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004; 22: 3099-3103. (Pubitemid 41103722)
6. Wilt TJ, Cowper DC, Gammack JK, Going DR, Nugent S, Borowsky SJ,. An evaluation of radical prostatectomy at Veteran's Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. Med Care. 1999; 37: 1046-1056.
7. Lund L, Borre M, Jacobsen J, et al. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study. Urology. 2008; 72: 1258-1262.
8. Kattan MW, Cowen ME, Miles BJ,. A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med. 1997; 12: 299-305. (Pubitemid 27212775)
9. Alibhai SMH, Naglie G, Nam R, Trachtenberg J, Krahn MD,. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol. 2003; 21: 3318-3327. (Pubitemid 46606266)
10. Froehner M, Koch R, Litz RJ, et al. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy. Urology. 2008; 72: 1252-1257.
11. Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR,. Pretreatment predictors of death from other causes in men with prostate cancer. J Urol. 2008; 180: 2447-2452.
12. Stier DM, Greenfield S, Lubeck DP, et al. Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer. Urology. 1999; 54: 424-429. (Pubitemid 29407014)
13. Daskivich T, Sadetsky N, Kaplan SH, Greenfield S, Litwin MS,. Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med. 2010; 170: 1396-1397.
14. Froehner M, Koch R, Litz RJ, et al. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy. Eur Urol. 2005; 47: 190-195. (Pubitemid 40126974)
15. Linn BS, Linn MW, Gurel L,. Cumulative illness rating scale. J Am Geriatr Soc. 1968; 16: 622-626.
16. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of cumulative illness rating scale. Psychiatry Res. 1992; 41: 237-248.
17. Extermann M,. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000; 36: 453-471. (Pubitemid 30136223)
18. Hudon C, Fortin M, Vanasse A,. Cumulative illness rating scale was a reliable and valid index in a family practice context. J Clin Epidemiol. 2005; 58: 603-608. (Pubitemid 40692726)
19. Prentice RL,. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrics. 1986; 73: 1-11.
20. Mackillop WJ, Groome PA, Zhang-Salomons J, et al. Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol. 1997; 15: 1261-1271. (Pubitemid 27106315)
21. Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y,. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 1994; 30: 221-228. (Pubitemid 24291133)
22. Boulos DL, Groome PA, Brundage MD, et al. Predictive validity of 5 comorbidity indices in prostate carcinoma patients treated with curative intent. Cancer. 2006; 106: 1804-1814.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373-383. (Pubitemid 17055592)
24. Kaplan MH, Feinstein AR,. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis. 1974; 27: 387-404.
25. Greenfield S, Apolone G, McNeil BJ, Cleary PD,. The importance of co-existent disease in the occurrence of postoperative complications and 1-year recovery in patients undergoing total hip replacement. Med Care. 1993; 31: 141-154.
26. Miller MD, Towers A,. A Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics. Pittsburgh, PA: University of Pittsburgh; 1991.
27. Salvi F, Miller MD, Grilli A, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc. 2008; 56: 1926-1931.
28. Sobin LH, Wittekind Ch, editors. TNM Classification of Malignant Tumors, 6th ed. New York, NY: Wiley-Liss; 2002.
29. Greene FL, Page DI, Fleming ID, et al, editors. AJCC Cancer Staging Manual, 6th ed. New York, NY: Springer; 2002.
30. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969-974. (Pubitemid 28445094)
31. Therneau T, Li H,. Computing the Cox model for case cohort designs. Lifetime Data Anal. 1999; 5: 99-112.
32. Langholz B, Jiao J,. Computational methods for case-cohort studies. Comput Stat Data Anal. 2007; 51: 3737-3748. (Pubitemid 46509540)
33. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007; 177: 2106-2131. (Pubitemid 46726449)
34. Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on prostate cancer [review]. Eur Urol. 2008; 53: 68-80. (Pubitemid 350166735)
35. Tewari A, Cole Johnson C, Divine G, et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol. 2004; 171: 1513-1519. (Pubitemid 38365408)
36. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM,. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003; 56: 221-229. (Pubitemid 36513483)
37. Rothman KJ, Greenland S,. Modern Epidemiology. 2nd ed. New York, NY: Lippincott Williams and Wilkins; 1998.
38. Penson DF, Albertsen PC, Nelson PS, Barry M, Stanford JL,. Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst. 2001; 93: 1822-1823. (Pubitemid 33150456)
39. Newschaffer CJ, Otani K, McDonald MK, Penberthy LT,. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst. 2000; 92: 613-621. (Pubitemid 30321303)
40. Albertsen P,. When is a death from prostate cancer not a death from prostate cancer? [editorial]. J Natl Cancer Inst. 2000; 92: 590-591. (Pubitemid 30321300)
41. Satariano WA, Ragland KE, Van Den Eeden SK,. Cause of death in men diagnosed with prostate carcinoma. Cancer. 1998; 83: 1180-1188. (Pubitemid 28419072)